Clinical Trial Update: The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the use of Onexton for moderate acne vulgaris in patients with skin of color, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Post-inflammatory Hyperpigmentation

Drugs mentioned

• Onexton

Snippet

Sponsor: Derm Research, PLLC | Conditions: Acne Vulgaris, Post Inflammatory Hyperpigmentation | Phase 4 | Status: COMPLETED | Results posted: 2019-02-19